Management of hyperlipidaemia after coronary revascularisation: follow up study.
Delacrétaz
E
E
Cardiology, University Hospital, CH-3010 Bern, Switzerland.
Michalopoulos
P G
PG
Ruiz
J
J
Saner
H
H
Meier
B
B
D015906:Angioplasty, Balloon, Coronary / Q000379:methods; D000925:Anticoagulants / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D001026:Coronary Artery Bypass / Q000379:methods; D003327:Coronary Disease / Q000097:blood / Q000150:complications / Q000188:drug therapy; D018752:Diet, Fat-Restricted; D005500:Follow-Up Studies; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000150:complications / Q000178:diet therapy / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D009204:Myocardial Revascularization / Q000379:methods*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012307:Risk Factors; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D000960:Hypolipidemic Agents; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin; D002784:Cholesterol